Adult Growth Hormone Deficiency Clinical Trials

Living with Adult Growth Hormone Deficiency?

Discover a New Path to Wellness Through Clinical Trials

Adult Growth Hormone Deficiency (AGHD) is a rare but serious condition characterized by the inadequate secretion of growth hormone (GH) in adults. This can lead to increased body fat, decreased muscle mass, reduced bone density, insulin resistance that can lead to Type 2 diabetes, and diminished quality of life. Unlike growth hormone deficiency in children, which affects development, AGHD primarily impacts physical function and metabolic health in adults.

Revival Research Institute is conducting Adult Growth Hormone Deficiency clinical trials to explore innovative treatment options. These studies aim to assess the safety and efficacy of investigational therapies that could potentially improve energy levels, cognitive function, body composition, and cardiovascular health in adults living with AGHD.

Are You Eligible to Participate?

To be eligible for our Adult Growth Hormone Deficiency clinical trials, individuals must meet the following criteria:

• Male or female, age ≥18 years
• Diagnosis of adult growth hormone deficiency (AGHD) as per local practice
• Patient and physician decided to start Sogroya® (somapacitan) treatment independently and prior to study participation

*Additional criteria may apply.

Participation in growth hormone deficiency clinical trials in Texas or other locations provides a chance to receive expert care, free study-related medication, and regular health monitoring by experienced medical professionals.

Get Started: What to Expect?

If you are living with adult growth hormone deficiency, you may qualify for a paid clinical trial focused on potential treatment options for both conditions. After completing the interest from above, a research team member will contact you for a brief pre-screening to see if you meet the initial eligibility criteria. If you qualify, you will be asked to review and sign an Informed Consent Form (ICF), which explains all study procedures, potential benefits, and risks.

Following your consent, you’ll be invited to a screening visit at our clinical research site. During this initial visit, we will ask questions about your medical history, perform physical exams, and run lab tests to further assess your eligibility. If you meet all study requirements, you will be officially enrolled in the clinical trial.

Our team will ensure you fully understand your role in the study and what to expect throughout the process. You are encouraged to ask any questions before enrolling. Your participation helps advance future treatments for adult growth hormone deficiency.